List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 170 studies with search of: "Tyrosine"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Tyrosine for Methamphetamine Dependence - 1
Condition: Amphetamine-Related Disorders
Intervention: Behavioral: Tyrosine
2 Recruiting Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes
Conditions: Hypereosinophilic Syndrome;   Systemic Mastocytosis;   Chronic Myelomonocytic Leukemia;   Dermatofibrosarcoma
Intervention: Drug: imatinib mesylate
3 Recruiting Malignant Pleural Effusion With ZD6474
Conditions: Lung Cancer;   Pleural Effusion
Intervention: Drug: ZD6474
4 Recruiting MP470 and Chemotherapy in Treating Patients With Cancer
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: carboplatin;   Drug: docetaxel;   Drug: erlotinib hydrochloride;   Drug: etoposide;   Drug: multitargeted receptor tyrosine kinase inhibitor MP470;   Drug: paclitaxel;   Drug: topotecan hydrochloride
5 Recruiting MP470 in Treating Patients With Unresectable or Metastatic Solid Tumor or Lymphoma
Conditions: Lymphoma;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: multitargeted receptor tyrosine kinase inhibitor MP470;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Procedure: positron emission tomography
6 Completed B181: Stimulation of Thermogenesis by Bio-Active Food Ingredients
Condition: Obesity
Intervention: Drug: tyrosine, green tea, caffeine
7 Recruiting Safety Study to Determine the Maximum Tolerated Dose, Pharmacokinetics and Pharmacodynamics of Oral MP470, a Multitargeted Tyrosine Kinase Inhibitor, in Patients With Solid Malignancies
Condition: Solid Malignancies
Intervention: Drug: MP-470
8 Active, not recruiting A Phase II Trial of Perifosine Following Tyrosine Kinase Inhibitor (TKI) - Failure in Patients With Renal Cancer
Condition: Renal Cell Carcinoma
Intervention: Drug: Perifosine
9 Recruiting First-Line EGFR-1 Tyrosine Kinase Inhibition in Patients With NSCLC With Mutant EGFR Gene
Conditions: Lung Neoplasms;   Non-Small Cell Lung Cancer;   Adenocarcinoma, Bronchiolo-Alveolar
Intervention: Drug: Erlotinib
10 Terminated Study of the Combination of a Tyrosine Kinase Inhibitor (STI571) and a Pegylated Human Recombinant Interferon alfa2b (PEGINTRON)
Condition: Chronic Myeloid Leukemia
Intervention: Drug: STI571 and PEG INTRON
11 Completed Protein-Tyrosine Kinase Inhibitor (STI571) for Treatment of Patients With Ph+ Chronic Myeloid Leukemia
Condition: Chronic Myeloid Leukemia
Intervention: Drug: STI571
12 Recruiting Phase II Trial to Correlate Radiographic Response Induced By Gefitinib With Mutations in the Protein-Tyrosine Kinase Domain of the EGF Receptor Gene
Conditions: Lung Cancer;   Non-Small Cell Lung Cancer;   Bronchioloalveolar Cancer
Intervention: Drug: Gefitinib
13 Completed Pharmacotoxicology of Trichloroethylene Metabolties
Condition: Healthy
Interventions: Drug: Dichloroacetate;   Genetic: Genotyping
14 Completed Dysregulated Tyrosine Kinase Signaling in Leukemia
Condition: Leukemia
Intervention:
15 Active, not recruiting Study Comparing 12 Months Versus 36 Months of Imatinib in the Treatment of Gastrointestinal Stromal Tumor (GIST)
Condition: Sarcoma
Interventions: Drug: imatinib mesylate;   Drug: imatinib;   Drug: imatinib
16 Completed A Pharmacokinetic Study of Genistein, a Tyrosine Kinase Inhibitor
Condition: Cancer
Intervention: Drug: Genistein
17 Recruiting Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma;   Kidney Cancer
Interventions: Drug: avastin;   Drug: temsirolimus
18 Active, not recruiting Pilot Study Using Neoadj Chemo-Rad & EGFR-Tyrosine Kinase Inhibitor for Potentially Resectable Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Drug: Tarceva
19 Suspended Evaluation of Safety and Tolerability of Tyrosine Adsorbed Ragweed Pollen Allergoid With MPL (Monophosphoryl Lipid A)
Condition: Type I Hypersensitivity
Intervention: Biological: RagweedMATAMPL
20 Active, not recruiting IMC-1121B in Patients With Metastatic Renal Cell Carcinoma With Disease Progression on or Intolerance to Tyrosine Kinase Inhibitor Therapy
Condition: Metastatic Renal Cell Carcinoma
Intervention: Drug: 1121B

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services